Table 2 Antibiotic treatment and surgical management of 61 patients with primary spondylodiscitis
Characteristic | All patients | ||
|---|---|---|---|
n* | %* | ||
Procedure | Surgery | 26 | 43 |
CT-guided drainage | 3 | 5 | |
Adequate empirical antibiotic therapy | 47 | 83 | |
Empirical therapy | Amoxicillin-clavulanate | 29 | 48 |
Flucloxacillin | 5 | 8 | |
Ceftriaxon | 9 | 15 | |
Piperacillin-tazobactam | 6 | 10 | |
Other beta-lactame antibiotics | 5 | 8 | |
Ciprofloxacin | 5 | 8 | |
Other | 2 | 3 | |
Switch to oral antibiotic treatment | 43 | 72 | |
Oral regimen | Ciprofloxacin or other chinolone alone | 15 | 35 |
Ciprofloxacin and clindamycin | 5 | 12 | |
Ciprofloxacin and rifampicin | 11 | 26 | |
Clindamycin alone | 3 | 7 | |
Other | 9 | 21 | |
Antibiotic regimen containing rifampicin | 15 | 25 | |
Median duration of total antibiotic therapy, IQR (days) | 57 | 44–83 | |